{"id":44791,"date":"2025-10-28T13:19:17","date_gmt":"2025-10-28T05:19:17","guid":{"rendered":"https:\/\/flcube.com\/?p=44791"},"modified":"2025-10-28T13:19:18","modified_gmt":"2025-10-28T05:19:18","slug":"wuxi-apptec-sells-wuxi-clinical-and-medkey-to-hillhouse-for-rmb-2-8-billion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=44791","title":{"rendered":"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion"},"content":{"rendered":"\n<p>WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd. (<a href=\"https:\/\/www.google.com\/finance\/quote\/603259:SHA\">SHA: 603259<\/a>, <a href=\"https:\/\/www.google.com\/finance\/quote\/2359:HKG\">HKG: 2359<\/a>), today announced the closing of a sale\u2011and\u2011purchase agreement with Hillhouse Investment Management (Hillhouse). Under the deal, WuXi AppTec will divest all shares in WuXi Clinical Development Services (Shanghai) Co., Ltd. (\u201cWuXi Clinical\u201d) and WuXi MedKey Med\u2011Tech Development (Shanghai) Co., Ltd. (\u201cWuXi MedKey\u201d) for a total cash consideration of <strong>RMB\u202f2.8\u202fbillion<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\"><strong>Strategic Rationale<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Core CRDMO Focus<\/strong> \u2013 The transaction aligns with WuXi AppTec\u2019s long\u2011term strategy to sharpen its core Contract Research, Development, Manufacturing, and Outsourcing (CRDMO) model, prioritising drug discovery, laboratory testing, process development and manufacturing services.<\/li>\n\n\n\n<li><strong>Portfolio Consolidation<\/strong> \u2013 By divesting the China\u2011based clinical research entities, WuXi AppTec will streamline its operations and re\u2011allocate capital to high\u2011growth platform businesses.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-impact-jan-sep-2025-unaudited\"><strong>Financial Impact (Jan\u2011Sep\u202f2025, Unaudited)<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>WuXi Clinical &amp; MedKey<\/th><th>% of Group (Q1\u2011Q3 2025)<\/th><\/tr><\/thead><tbody><tr><td>Revenue<\/td><td>RMB\u202f1.16\u202fbn<\/td><td>3.5\u202f%<\/td><\/tr><tr><td>Net Profit<\/td><td>RMB\u202f0.09\u202fbn<\/td><td>0.7\u202f%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>The sale is expected to have a minimal impact on the group\u2019s consolidated performance, given the modest contribution of the divested entities to overall revenue and earnings.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-details\"><strong>Deal Details<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Transaction Value<\/strong> \u2013 RMB\u202f2.8\u202fbn in cash.<\/li>\n\n\n\n<li><strong>Buyer<\/strong> \u2013 Hillhouse Investment Management, a leading investment arm with a focus on life\u2011science enterprises.<\/li>\n\n\n\n<li><strong>Seller<\/strong> \u2013 WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2025102600017.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2025102600017.\"><\/object><a id=\"wp-block-file--media-d756a34f-aadc-44a5-b8ae-998f6269f7ea\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2025102600017.pdf\">2025102600017<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2025102600017.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-d756a34f-aadc-44a5-b8ae-998f6269f7ea\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd. (SHA: 603259,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":44793,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[951,1078,362],"class_list":["post-44791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-hkg-2359","tag-sha-603259","tag-wuxi-apptec"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd. (SHA: 603259, HKG: 2359), today announced the closing of a sale\u2011and\u2011purchase agreement with Hillhouse Investment Management (Hillhouse). Under the deal, WuXi AppTec will divest all shares in WuXi Clinical Development Services (Shanghai) Co., Ltd. (\u201cWuXi Clinical\u201d) and WuXi MedKey Med\u2011Tech Development (Shanghai) Co., Ltd. (\u201cWuXi MedKey\u201d) for a total cash consideration of RMB\u202f2.8\u202fbillion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=44791\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion\" \/>\n<meta property=\"og:description\" content=\"WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd. (SHA: 603259, HKG: 2359), today announced the closing of a sale\u2011and\u2011purchase agreement with Hillhouse Investment Management (Hillhouse). Under the deal, WuXi AppTec will divest all shares in WuXi Clinical Development Services (Shanghai) Co., Ltd. (\u201cWuXi Clinical\u201d) and WuXi MedKey Med\u2011Tech Development (Shanghai) Co., Ltd. (\u201cWuXi MedKey\u201d) for a total cash consideration of RMB\u202f2.8\u202fbillion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=44791\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-28T05:19:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T05:19:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2802.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion\",\"datePublished\":\"2025-10-28T05:19:17+00:00\",\"dateModified\":\"2025-10-28T05:19:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791\"},\"wordCount\":254,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2802.webp\",\"keywords\":[\"HKG: 2359\",\"SHA: 603259\",\"WuXi AppTec\"],\"articleSection\":[\"Others\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44791#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=44791\",\"name\":\"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2802.webp\",\"datePublished\":\"2025-10-28T05:19:17+00:00\",\"dateModified\":\"2025-10-28T05:19:18+00:00\",\"description\":\"WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd. (SHA: 603259, HKG: 2359), today announced the closing of a sale\u2011and\u2011purchase agreement with Hillhouse Investment Management (Hillhouse). Under the deal, WuXi AppTec will divest all shares in WuXi Clinical Development Services (Shanghai) Co., Ltd. (\u201cWuXi Clinical\u201d) and WuXi MedKey Med\u2011Tech Development (Shanghai) Co., Ltd. (\u201cWuXi MedKey\u201d) for a total cash consideration of RMB\u202f2.8\u202fbillion.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44791\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2802.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2802.webp\",\"width\":1080,\"height\":608,\"caption\":\"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44791#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion - Insight, China&#039;s Pharmaceutical Industry","description":"WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd. (SHA: 603259, HKG: 2359), today announced the closing of a sale\u2011and\u2011purchase agreement with Hillhouse Investment Management (Hillhouse). Under the deal, WuXi AppTec will divest all shares in WuXi Clinical Development Services (Shanghai) Co., Ltd. (\u201cWuXi Clinical\u201d) and WuXi MedKey Med\u2011Tech Development (Shanghai) Co., Ltd. (\u201cWuXi MedKey\u201d) for a total cash consideration of RMB\u202f2.8\u202fbillion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=44791","og_locale":"en_US","og_type":"article","og_title":"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion","og_description":"WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd. (SHA: 603259, HKG: 2359), today announced the closing of a sale\u2011and\u2011purchase agreement with Hillhouse Investment Management (Hillhouse). Under the deal, WuXi AppTec will divest all shares in WuXi Clinical Development Services (Shanghai) Co., Ltd. (\u201cWuXi Clinical\u201d) and WuXi MedKey Med\u2011Tech Development (Shanghai) Co., Ltd. (\u201cWuXi MedKey\u201d) for a total cash consideration of RMB\u202f2.8\u202fbillion.","og_url":"https:\/\/flcube.com\/?p=44791","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-28T05:19:17+00:00","article_modified_time":"2025-10-28T05:19:18+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2802.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=44791#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=44791"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion","datePublished":"2025-10-28T05:19:17+00:00","dateModified":"2025-10-28T05:19:18+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=44791"},"wordCount":254,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=44791#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2802.webp","keywords":["HKG: 2359","SHA: 603259","WuXi AppTec"],"articleSection":["Others"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=44791#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=44791","url":"https:\/\/flcube.com\/?p=44791","name":"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=44791#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=44791#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2802.webp","datePublished":"2025-10-28T05:19:17+00:00","dateModified":"2025-10-28T05:19:18+00:00","description":"WuXi AppTec (Shanghai) Co., Ltd., a wholly\u2011owned subsidiary of Wuxi AppTec Co., Ltd. (SHA: 603259, HKG: 2359), today announced the closing of a sale\u2011and\u2011purchase agreement with Hillhouse Investment Management (Hillhouse). Under the deal, WuXi AppTec will divest all shares in WuXi Clinical Development Services (Shanghai) Co., Ltd. (\u201cWuXi Clinical\u201d) and WuXi MedKey Med\u2011Tech Development (Shanghai) Co., Ltd. (\u201cWuXi MedKey\u201d) for a total cash consideration of RMB\u202f2.8\u202fbillion.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=44791#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=44791"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=44791#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2802.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2802.webp","width":1080,"height":608,"caption":"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=44791#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"WuXi AppTec Sells WuXi Clinical and MedKey to Hillhouse for RMB\u202f2.8\u202fBillion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2802.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=44791"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44791\/revisions"}],"predecessor-version":[{"id":44794,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44791\/revisions\/44794"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/44793"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=44791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=44791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=44791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}